Company intelligence / Profile preview

Hefei KS-V Peptide Biotechnology

Hefei, Anhui, China

Ownership: Private
Employees: ~150
Development stage: Other

Overview

Hefei KS-V Peptide Biotechnology is a specialty contract research and manufacturing organization (CRO/CDMO) that provides high-throughput peptide synthesis, custom peptide modifications, and peptide library construction services to global pharmaceutical and academic institutions. The company focuses on the development of complex peptide-based therapeutics including cyclic peptides and peptide-drug conjugates.

Modalities: PeptidesPeptide-drug conjugate
Industry: Contract Research Organization

Beyond the preview

Go deeper on Hefei KS-V Peptide Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hefei KS-V Peptide Biotechnology.

Explore the full profile